In VitroAntigene Therapy Targeting HPV-16 E6 and E7 in Cervical Carcinoma

By Madrigal M.   Janicek M.F.   Sevin B.-U.   Perras J.   Estape R.   Penalver M.   Averette H.E.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 18-25

Elsevier

Access to resources Recommend Favorite

Adenovirus-Mediated Transfer of HPV 16 E6/E7 Antisense RNA to Human Cervical Cancer Cells

By Hamada K.   Sakaue M.   Alemany R.   Zhang W.W.   Horio Y.   Roth J.A.   Mitchell M.F.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 219-227

Academic Press

Access to resources Recommend Favorite

The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with Stage of Cervical Cancer

By Fisher S.G.   Benitez-Bribiesca L.   Nindl I.   Stockfleth E.   Muller M.   Wolf H.   Perez-Garcia F.   Guzman-Gaona J.   Gutierrez-delgado F.   Irvin W.   Gissmann L.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 73-78

Academic Press

Access to resources Recommend Favorite

Human Papillomavirus Type 16 E6 and E7 Gene Variations in Indian Cervical Cancer

By Radhakrishna Pillai M.   Sreevidya S.   Pollock B.H.   Jayaprakash P.G.   Herman B.  

Gynecologic Oncology, Vol. 87, Iss. 3, 2002-12 ,pp. : 268-273

Academic Press

Access to resources Recommend Favorite

The role of human papillomavirus type 16 E6/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinogenesis

By          

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 667-671

Spandidos Publications

Access to resources Recommend Favorite